These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
409 related items for PubMed ID: 35460419
1. Presence of adenomyosis at MRI reduces live birth rates in ART cycles for endometriosis. Bourdon M, Santulli P, Bordonne C, Millisher AE, Maitrot-Mantelet L, Maignien C, Marcellin L, Melka L, Chapron C. Hum Reprod; 2022 Jun 30; 37(7):1470-1479. PubMed ID: 35460419 [Abstract] [Full Text] [Related]
4. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A. Hum Reprod; 2016 Jun 30; 31(6):1253-64. PubMed ID: 27060174 [Abstract] [Full Text] [Related]
7. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder. Oudshoorn SC, van Tilborg TC, Eijkemans MJC, Oosterhuis GJE, Friederich J, van Hooff MHA, van Santbrink EJP, Brinkhuis EA, Smeenk JMJ, Kwee J, de Koning CH, Groen H, Lambalk CB, Mol BWJ, Broekmans FJM, Torrance HL, OPTIMIST study group. Hum Reprod; 2017 Dec 01; 32(12):2506-2514. PubMed ID: 29121269 [Abstract] [Full Text] [Related]
8. Using serum anti-Müllerian hormone levels to predict the chance of live birth after spontaneous or assisted conception: a systematic review and meta-analysis. Peigné M, Bernard V, Dijols L, Creux H, Robin G, Hocké C, Grynberg M, Dewailly D, Sonigo C. Hum Reprod; 2023 Sep 05; 38(9):1789-1806. PubMed ID: 37475164 [Abstract] [Full Text] [Related]
12. Low anti-Müllerian hormone level is not a risk factor for early pregnancy loss in IVF/ICSI treatment. Peuranpää P, Hautamäki H, Halttunen-Nieminen M, Hydén-Granskog C, Tiitinen A. Hum Reprod; 2020 Mar 27; 35(3):504-515. PubMed ID: 32219343 [Abstract] [Full Text] [Related]
14. Predicting cumulative live birth for couples beginning their second complete cycle of in vitro fertilization treatment. Ratna MB, Bhattacharya S, van Geloven N, McLernon DJ. Hum Reprod; 2022 Aug 25; 37(9):2075-2086. PubMed ID: 35866894 [Abstract] [Full Text] [Related]
15. Women with combined adenomyosis and endometriosis on MRI have worse IVF/ICSI outcomes compared to adenomyosis and endometriosis alone: A matched retrospective cohort study. Rees CO, Rupert IAM, Nederend J, Consten D, Mischi M, A A M van Vliet H, Schoot BC. Eur J Obstet Gynecol Reprod Biol; 2022 Apr 25; 271():223-234. PubMed ID: 35231748 [Abstract] [Full Text] [Related]
18. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder. van Tilborg TC, Torrance HL, Oudshoorn SC, Eijkemans MJC, Koks CAM, Verhoeve HR, Nap AW, Scheffer GJ, Manger AP, Schoot BC, Sluijmer AV, Verhoeff A, Groen H, Laven JSE, Mol BWJ, Broekmans FJM, OPTIMIST study group. Hum Reprod; 2017 Dec 01; 32(12):2496-2505. PubMed ID: 29121326 [Abstract] [Full Text] [Related]
19. Oocyte donation outcomes in endometriosis patients with multiple IVF failures. Maignien C, Hachem RE, Bourdon M, Marcellin L, Chalas C, Patrat C, Gonzàlez-Foruria I, Chapron C, Santulli P. Reprod Biomed Online; 2023 Aug 01; 47(2):103236. PubMed ID: 37390602 [Abstract] [Full Text] [Related]
20. Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients. Sharma S, Bathwal S, Agarwal N, Chattopadhyay R, Saha I, Chakravarty B. Reprod Biomed Online; 2019 Jan 01; 38(1):13-21. PubMed ID: 30446308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]